Palivizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Palivizumab and local guidelines before prescribing.

Antiviral antibody

Mechanism

RSV fusion protein monoclonal antibody.

Uses

RSV prophylaxis in high-risk infants.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reaction, fever, rash.

Interactions

Few.

Contraindications and cautions

Hypersensitivity

Monitoring

Infant respiratory status

Pregnancy and breastfeeding

Not applicable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Monthly in RSV season.

More from the textbook: uses, cautions and other points
Where it is discussed in the book